Julkunen, Heli http://orcid.org/0000-0002-4282-0248
Cichońska, Anna
Tiainen, Mika
Koskela, Harri
Nybo, Kristian
Mäkelä, Valtteri
Nokso-Koivisto, Jussi
Kristiansson, Kati http://orcid.org/0000-0003-4688-107X
Perola, Markus
Salomaa, Veikko http://orcid.org/0000-0001-7563-5324
Jousilahti, Pekka http://orcid.org/0000-0001-7190-0979
Lundqvist, Annamari
Kangas, Antti J.
Soininen, Pasi
Barrett, Jeffrey C.
Würtz, Peter
Article History
Received: 28 June 2022
Accepted: 20 January 2023
First Online: 3 February 2023
Competing interests
: H.J., M.T., H.K., K.N., V.M., J.N.-K., A.J.K., P.S., J.B., and P.W. are employees of Nightingale Health Plc, and hold shares or stock options in Nightingale Health Plc. A.C. is former employee of Nightingale Health Plc. V.S. has received an honorarium for consulting from Sanofi and has ongoing research collaboration with Bayer Ltd outside this work. The remaining authors declare no competing interests.